Skip to main content

Advertisement

Log in

Clinical manifestations of neurological involvement in primary Sjögren’s syndrome

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The aim of this study was to evaluate neurological manifestations of primary Sjögren’s syndrome (pSS) and investigate the etiology and pathogenesis of peripheral and central nervous complications in pSS. Thirty-two patients with pSS were enrolled in the present study, 20 of whom had neurological involvement plus sicca symptoms. The clinical features were evaluated by neurological examinations including nerve conduction study, magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram. The frequency of fever was significantly higher (P = 0.006) in pSS with neurological involvement than in pSS without neurological involvement. There was no statistical significance in other factors between the two groups. Peripheral nervous system (PNS), central nervous system (CNS), and both PNS and CNS involvements were revealed in 14, 3, and 3 patients, respectively. Optic neuritis and trigeminal neuralgia were revealed frequently in cranial neuropathy. Anti-aquaporin 4 antibody was detected in one patient with optic neuritis. Of the nine patients with polyneuropathy, eight patients presented pure sensory neuropathy including small fiber neuropathy (SFN). pSS with SFN appeared to have no clinically abnormal features, including muscle weakness and decreasing deep tendon reflex. Skin biopsy revealed epidermal nerve fiber degenerated in one pSS patient with pure sensory neuropathy who was diagnosed as having SFN. Our observations suggest that a number of mechanisms can be attributed to neurological involvements in pSS rather than just the mechanisms previously described (i.e., vasculitis and ganglioneuronitis). Presumably, specific autoantibodies may directly induce injury of the nervous system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Alexander E, Provost T, Stevens M, Alexander G (1982) Neurologic complications of primary Sjögren’s syndrome. Medicine (Baltimore) 61(4):247–257

    CAS  Google Scholar 

  2. Griffin J, Cornblath D, Alexander E, Campbell J, Low P, Bird S et al (1990) Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren’s syndrome. Ann Neurol 27(3):304–315

    Article  PubMed  CAS  Google Scholar 

  3. Mellgren S, Conn D, Stevens J, Dyck P (1989) Peripheral neuropathy in primary Sjögren’s syndrome. Neurology 39(3):390–394

    PubMed  CAS  Google Scholar 

  4. Hebbar M, Hebbar-Savean K, Hachulla E, Brouillard M, Hatron P, Devulder B (1995) Participation of cryoglobulinaemia in the severe peripheral neuropathies of primary Sjögren’s syndrome. Ann Med Interne (Paris) 146(4):235–238

    CAS  Google Scholar 

  5. Alexander E, Ranzenbach M, Kumar A, Kozachuk W, Rosenbaum A, Patronas N et al (1994) Anti-Ro(SS-A) autoantibodies in central nervous system disease associated with Sjögren’s syndrome (CNS-SS): clinical, neuroimaging, and angiographic correlates. Neurology 44(5):899–908

    PubMed  CAS  Google Scholar 

  6. Lecky B, Hughes R, Murray N (1987) Trigeminal sensory neuropathy. A study of 22 cases. Brain 110(Pt 6):1463–1485

    Article  PubMed  Google Scholar 

  7. Satake M, Yoshimura T, Iwaki T, Yamada T, Kobayashi T (1995) Anti-dorsal root ganglion neuron antibody in a case of dorsal root ganglionitis associated with Sjögren’s syndrome. J Neurol Sci 132(2):122–125

    Article  PubMed  CAS  Google Scholar 

  8. Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H et al (2005) The wide spectrum of clinical manifestations in Sjögren’s syndrome-associated neuropathy. Brain 128(Pt 11):2518–2534

    Article  PubMed  Google Scholar 

  9. Hoitsma E, Reulen J, de Baets M, Drent M, Spaans F, Faber C (2004) Small fiber neuropathy: a common and important clinical disorder. J Neurol Sci 227(1):119–130

    Article  PubMed  CAS  Google Scholar 

  10. Al-Shekhlee A, Chelimsky T, Preston D (2002) Review: small-fiber neuropathy. Neurologist 8(4):237–253

    Article  PubMed  Google Scholar 

  11. Chai J, Herrmann D, Stanton M, Barbano R, Logigian E (2005) Painful small-fiber neuropathy in Sjogren syndrome. Neurology 65(6):925–927

    Article  PubMed  CAS  Google Scholar 

  12. Wakasugi D, Kato T, Gono T, Ito E, Nodera H, Kawaguchi Y et al (2009) Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjögren’s syndrome. Mod Rheumatol 19:437–440

    Article  PubMed  Google Scholar 

  13. Alexander E, Malinow K, Lejewski J, Jerdan M, Provost T, Alexander G (1986) Primary Sjögren's syndrome with central nervous system disease mimicking multiple sclerosis. Ann Intern Med 104(3):323–330

    PubMed  CAS  Google Scholar 

  14. Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M et al (2007) Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 130(Pt 5):1235–1243

    Article  PubMed  Google Scholar 

  15. Wingerchuk D, Hogancamp W, O'Brien P, Weinshenker B (1999) The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 53(5):1107–1114

    PubMed  CAS  Google Scholar 

  16. Wingerchuk D, Lennon V, Lucchinetti C, Pittock S, Weinshenker B (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6(9):805–815

    Article  PubMed  CAS  Google Scholar 

  17. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos H, Alexander E, Carsons S et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 61(6):554–558

    Article  PubMed  CAS  Google Scholar 

  18. McArthur J, Stocks E, Hauer P, Cornblath D, Griffin J (1998) Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol 55(12):1513–1520

    Article  PubMed  CAS  Google Scholar 

  19. Delalande S, de Seze J, Fauchais A, Hachulla E, Stojkovic T, Ferriby D et al (2004) Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 83(5):280–291

    Article  Google Scholar 

  20. Gøransson L, Brun J, Harboe E, Mellgren S, Omdal R (2006) Intraepidermal nerve fiber densities in chronic inflammatory autoimmune diseases. Arch Neurol 63(10):1410–1413

    Article  PubMed  Google Scholar 

  21. Lopate G, Pestronk A, Al-Lozi M, Lynch T, Florence J, Miller T et al (2006) Peripheral neuropathy in an outpatient cohort of patients with Sjögren’s syndrome. Muscle Nerve 33(5):672–676

    Article  PubMed  Google Scholar 

  22. Moll J, Markusse H, Pijnenburg J, Vecht C, Henzen-Logmans S (1993) Antineuronal antibodies in patients with neurologic complications of primary Sjögren’s syndrome. Neurology 43(12):2574–2581

    PubMed  CAS  Google Scholar 

  23. Waterman S, Gordon T, Rischmueller M (2000) Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren’s syndrome. Arthritis Rheum 43(7):1647–1654

    Article  PubMed  CAS  Google Scholar 

  24. Smith A, Jackson M, Wang F, Cavill D, Rischmueller M, Gordon T (2005) Neutralization of muscarinic receptor autoantibodies by intravenous immunoglobulin in Sjögren syndrome. Hum Immunol 66(4):411–416

    Article  PubMed  CAS  Google Scholar 

  25. Orman B, Sterin-Borda L, De Couto Pita A, Reina S, Borda E (2007) Anti-brain cholinergic auto antibodies from primary Sjögren syndrome sera modify simultaneously cerebral nitric oxide and prostaglandin biosynthesis. Int Immunopharmacol 7(12):1535–1543

    Article  PubMed  CAS  Google Scholar 

  26. Ishida K, Uchihara T, Mizusawa H (2007) Recurrent aseptic meningitis: a new CSF complication of Sjogren’s syndrome. J Neurol 254(6):806–807

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Dr. Hiroyuki Nodera for staining of the skin biopsies and Dr. Toshiyuki Takahashi, Yasuto Itoyama, and Keiko Tanaka for detection of the anti-aquaporin 4 antibody. This study was supported by research grants from the Ministry of Health, Labour and Welfare in Japan.

Disclosures

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasushi Kawaguchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gono, T., Kawaguchi, Y., Katsumata, Y. et al. Clinical manifestations of neurological involvement in primary Sjögren’s syndrome. Clin Rheumatol 30, 485–490 (2011). https://doi.org/10.1007/s10067-010-1458-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-010-1458-7

Keywords

Navigation